Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KRE vs MRNA✓SelectedUSD · MRNAKRE vs MRNA performance historyLatest closeAs of-1.36%11/20
Stock and ETF performance explorer

KRE vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+64.1%
MRNA return
+153.9%
Excess return
-89.8%
Maximum drawdown
-28.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.4%-2.2%+0.8%-1.3%
7D-6.1%-12.7%+6.6%-5.9%
30D-3.3%-20.7%+17.4%-3.0%
3M-8.0%+46.3%-54.3%-8.7%
6M-0.1%+305.2%-305.3%-6.9%
YTD+7.3%+561.2%-554.0%-6.7%
1Y+17.4%+772.1%-754.7%-1.5%
3Y+64.1%+147.0%-82.9%+43.5%
All+64.1%+153.9%-89.8%+43.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling